Assuntos
Angioedema/induzido quimicamente , Angioedema/tratamento farmacológico , Antagonistas de Receptor B2 da Bradicinina/uso terapêutico , Bradicinina/análogos & derivados , N-Metil-3,4-Metilenodioxianfetamina/toxicidade , Adulto , Angioedema/diagnóstico , Bradicinina/administração & dosagem , Bradicinina/uso terapêutico , Antagonistas de Receptor B2 da Bradicinina/administração & dosagem , Humanos , Masculino , Resultado do TratamentoRESUMO
A study was performed to assess differences in the clinical presentation of tuberculosis between two groups of immigrants. Ninety-four patients seen in the emergency room for newly diagnosed tuberculosis between 2006 and 2012 were included. Forty-nine patients were from Asian countries and 45 from Latin America. Mean age [years (SD)] was 35.3 (13) in Asian patients and 33.9 (10) in Latin American patients. Asian subjects were predominantly male (40/49 vs 25/45; P=0.006). Patients from Latin American countries had a higher rate of pulmonary tuberculosis. A higher percentage of Asian patients lived in overcrowded conditions, whereas HIV infection was more frequent among Latin Americans. Most patients were treated with a quadruple regimen. Resistance to isoniazid was documented in two patients from Latin America.
Assuntos
Emigrantes e Imigrantes/estatística & dados numéricos , Tuberculose/etnologia , Adulto , Antituberculosos/farmacologia , Antituberculosos/uso terapêutico , Ásia/etnologia , Comorbidade , Aglomeração , Farmacorresistência Bacteriana , Quimioterapia Combinada , Serviço Hospitalar de Emergência/estatística & dados numéricos , Feminino , Infecções por HIV/epidemiologia , Hospitais Universitários/estatística & dados numéricos , Humanos , Isoniazida/farmacologia , Isoniazida/uso terapêutico , América Latina/etnologia , Masculino , Paquistão/etnologia , Quartos de Pacientes/estatística & dados numéricos , Estudos Retrospectivos , Espanha/epidemiologia , Tuberculose/tratamento farmacológico , Tuberculose/microbiologia , Tuberculose Pulmonar/tratamento farmacológico , Tuberculose Pulmonar/etnologia , Tuberculose Pulmonar/microbiologia , Adulto JovemRESUMO
Electrical shock can cause a direct myocardial damage and different types of arrhythmias, which are uncommon and occur more often when there is a high voltage exposure. We report a 19-year-old male that received a high voltage shock, falling thereafter from an altitude of four meters. On admission to the emergency room, he had second and third degree burns in the right hand and the left thigh. The electrocardiogram showed a nodal rhythm of 72 beats per minute. After four hours of monitoring, sinus rhythm returned spontaneously.
Assuntos
Humanos , Masculino , Adulto Jovem , Arritmias Cardíacas/etiologia , Traumatismos por Eletricidade/complicações , Arritmias Cardíacas/fisiopatologia , Eletrocardiografia , Remissão EspontâneaRESUMO
Electrical shock can cause a direct myocardial damage and different types of arrhythmias, which are uncommon and occur more often when there is a high voltage exposure. We report a 19-year-old male that received a high voltage shock, falling thereafter from an altitude of four meters. On admission to the emergency room, he had second and third degree burns in the right hand and the left thigh. The electrocardiogram showed a nodal rhythm of 72 beats per minute. After four hours of monitoring, sinus rhythm returned spontaneously.
Assuntos
Arritmias Cardíacas/etiologia , Traumatismos por Eletricidade/complicações , Arritmias Cardíacas/fisiopatologia , Eletrocardiografia , Humanos , Masculino , Remissão Espontânea , Adulto JovemRESUMO
The aim of this study was to reduce the door-to-needle time in patients with ST-elevation acute myocardial infarction by setting up a chest pain service. We compared the door-to-needle time and outcomes at the end of first year of follow-up in patients who received fibrinolysis in the 2 years before implementation of the service (Group 1) and those who received fibrinolysis in the 2 years after its creation (Group 2). In Group 1, the median door-to-needle time was 40 min (P(25-75), 23-52 min); in Group 2, it was 27 min (P(25-75), 15-43 min; P=.003). In addition, the use of reperfusion therapy increased from 55.2% in Group 1 to 64.7% in Group 2 (P< .01). After a follow-up period of 1 year, there was no difference in the rate of revascularization, hospital readmission, reinfarction or cardiovascular mortality.